HOW TO REDUCE RESISTANCE TO ANTIBACTERIAL THERAPY?
https://doi.org/10.21518/2079-701X-2017-19-84-89
Abstract
Development of antibacterial agents became one of the greatest inventions of the previous century. The effective counteraction to infectious disease agents allowed saving lives of many patients. But in our day-to-day activities we face the reverse side of the widespread use of such drugs: growth of resistance to them and increase of side effects. This can’t but cause concern of the medical community. On the one hand, this problem was urgent at the end of the 90s when due to various reasons a process of development and implementation of new antimicrobials reduced. On the other hand, wide uncontrolled use of antibiotics due to their availability and low adequacy of prescription led to increase of resistance development to them of various microorganisms.
About the Authors
I. N. Kholodova
Russian Medical Academy of Continuous Postgraduate Education of the Ministry of Health of Russia
Russian Federation
Russian Federation
MD, Prof.,
Moscow
D. I. Kholodov
Russian Medical Academy of Continuous Postgraduate Education of the Ministry of Health of Russia
Russian Federation
Moscow
Russian Federation
Moscow
References
1. ECDC/EMEA Joint Technical Report: The bacterial challenge: Time to react, September, 2009.
2. Сидоренко С.В., Яковлев С.В., Спичак Т.В. и др. Стратегия и тактика рационального применения антимикробных средств в амбулаторной практике. Евразийские клинические рекомендации. Consilium Medicum. Педиатрия (приложение), 2016, 4: 10-20.
3. Сидоренко С.В., Яковлев С.В., Спичак Т.В. и др. Стратегия и тактика рационального применения антимикробных средств в амбулаторной практике. Евразийские клинические рекомендации. Consilium Medicum. Педиатрия (приложение), 2017, 1: 17-25.
4. Schlemmer B. Impact of registration procedures on antibiotic polices. Clin Microbiol Infect Dis, 2001, 7 (Suppl.6): 5-8.
5. Рейтинг научных заблуждений Россиян, ВЦИОМ, 2011.
6. Gonzales R, Steiner JF, Sande MA. Antibiotic prescribing for adults with colds, upper respiratori tract infection, and bronchitis by ambulatory care physicians. JAMA, 1997, 278: 901-4.
7. Hickner JM, Bartlett JG, Besser RE et al. Principles of appropriate antibiotic use for acute rhinosinusitis in adults: backround. Ann Intern MED, 2001, 134 (6): 498-505.
8. Fujita K, Murono K, Yoshikawa M, Murai T. Declin of eritromycin resistance of group A streptococci in Japan. Pediatr Infect Dis J, 1994, 13: 1075-8.
9. Захарова И.Н., Холодова И.Н. Новые технологии в лечении ОРИ у детей. Медицинский Совет, 2016, 7: 50-56.
10. Холодова И.Н., Сырьева Т.Н. Средства природного природного происхождения при лечении кашля у детей. ММА «МедиаМедика». Участковый педиатр, 2015, 4: 24.
11. Привалова Т.Е., Шадрин С.А., Шадрина Э.М. Новые фитопрепараты при лечении кашля у детей младших возрастных групп с острыми респираторными инфекциями. Вопросы современной медицины, 2007, 6(4): 128–131.
12. Brendler T, van Wyk BE. A historical, scientificand commercial perspective on the medical use of Pelargonium sidoides (Geraniaceae). J. Ethnopharmacol., 2008, 119: 420–433.
13. Kolodziej H, Kiderlen AF. In vitro evaluation of antibacterial and immunomodulatory activities of Pelargonium reniforme, Pelargonium sidoides and related herbal drug рreparation EPs 7630. Phytomedicine, 2007, 14: 18–26.
14. Григорян С.С., Гаращенко Т.И., Исаева Е.К., Притчина Е.К., Бакалов В.В. Противовирусное действие препарата Умкалор на продукцию вируса in vitrо. Детская оториноларингология, 2014, 2: 1-4.
15. Bereznoy V, Riley D, Wassmer G, Heger M. Efficacy of extract of Pelargonium sidoides in children with acute non-group A beta-hemolytis Streptococcus tonsillopharygits, a randomized, double-blind, placebocontrolled trial. Alternative Therapies, 2003, 9(5): 68–79.
16. Conrad A et al. Phytomedicine, 2007, 14(Suppl. VI): 52-59.
17. Matthys H, Heger M. Treatment of acute bronchitis with liquid herbal drug preparation from Pelargonium sidoides (EPs 7630): A randomized, doubleblind,ьplacebo-controlled multicentre study. Curr. Res. Opin., 2007, 23: 323–331.
18. Ёлкина Т.Н., Грибанова О.А. Монотерапия острых респираторных инфекций препаратом «Умкалор». РМЖ, 2008, 16(29).
19. Tahan F, Yaman M. Phytomedicine, 2013, 20(2): 148-50.
Review
For citations:
Kholodova IN, Kholodov DI. HOW TO REDUCE RESISTANCE TO ANTIBACTERIAL THERAPY? Meditsinskiy sovet = Medical Council. 2017;(19):84-89. (In Russ.) https://doi.org/10.21518/2079-701X-2017-19-84-89
Views:
672
Email this article 